New York State Common Retirement Fund
RARE icon

New York State Common Retirement Fund’s Ultragenyx Pharmaceutical RARE Stock Holding History

New York State Common Retirement Fund’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Hold
33,700
– – ﹤0.01% 1700
2026
Q1 		$706K Sell
33,700
-324
-1% -$7.3K ﹤0.01% 1789
2025
Q4 		$783K Sell
34,024
-1,322
-4% -$43.5K ﹤0.01% 1799
2025
Q3 		$1.06M Sell
35,346
-3,600
-9% -$108K ﹤0.01% 1662
2025
Q2 		$1.42M Sell
38,946
-22,721
-37% -$819K ﹤0.01% 1528
2025
Q1 		$2.23M Buy
61,667
+3,096
+5% +$129K ﹤0.01% 1331
2024
Q4 		$2.46M Sell
58,571
-5,000
-8% -$248K ﹤0.01% 1343
2024
Q3 		$3.53M Buy
63,571
+8,847
+16% +$451K ﹤0.01% 1224
2024
Q2 		$2.25M Sell
54,724
-7,524
-12% -$321K ﹤0.01% 1434
2024
Q1 		$2.91M Sell
62,248
-10,618
-15% -$501K ﹤0.01% 1322
2023
Q4 		$3.48M Buy
72,866
+19,673
+37% +$763K ﹤0.01% 1245
2023
Q3 		$1.9M Sell
53,193
-11,253
-17% -$446K ﹤0.01% 1471
2023
Q2 		$2.97M Buy
64,446
+2,117
+3% +$98.2K ﹤0.01% 1358
2023
Q1 		$2.5M Sell
62,329
-7,271
-10% -$312K ﹤0.01% 1453
2022
Q4 		$3.22M Sell
69,600
-54,395
-44% -$2.14M ﹤0.01% 1397
2022
Q3 		$5.13M Sell
123,995
-50,635
-29% -$2.6M 0.01% 1142
2022
Q2 		$10.4M Sell
174,630
-10,410
-6% -$641K 0.01% 856
2022
Q1 		$13.4M Buy
185,040
+1,637
+0.9% +$114K 0.01% 828
2021
Q4 		$15.4M Sell
183,403
-8,043
-4% -$654K 0.02% 796
2021
Q3 		$17.3M Buy
191,446
+3,741
+2% +$338K 0.02% 739
2021
Q2 		$17.9M Buy
187,705
+29,799
+19% +$3.1M 0.02% 725
2021
Q1 		$18M Buy
157,906
+10,100
+7% +$1.37M 0.02% 689
2020
Q4 		$20.5M Buy
147,806
+16,812
+13% +$1.99M 0.02% 634
2020
Q3 		$10.8M Buy
130,994
+3,100
+2% +$257K 0.01% 815
2020
Q2 		$10M Buy
127,894
+78,494
+159% +$5.2M 0.01% 865
2020
Q1 		$2.19M Buy
49,400
+300
+0.6% +$15.6K ﹤0.01% 1371
2019
Q4 		$2.1M Sell
49,100
-8,400
-15% -$347K ﹤0.01% 1610
2019
Q3 		$2.46M Buy
57,500
+1,500
+3% +$81.5K ﹤0.01% 1533
2019
Q2 		$3.56M Buy
56,000
+3,100
+6% +$197K ﹤0.01% 1392
2019
Q1 		$3.67M Buy
52,900
+6,800
+15% +$389K ﹤0.01% 1361
2018
Q4 		$2M Sell
46,100
-7,500
-14% -$410K ﹤0.01% 1556
2018
Q3 		$4.09M Buy
53,600
+1,300
+2% +$106K ﹤0.01% 1355
2018
Q2 		$4.02M Buy
52,300
+4,500
+9% +$291K 0.01% 1351
2018
Q1 		$2.44M Buy
47,800
+4,600
+11% +$232K ﹤0.01% 1524
2017
Q4 		$2M Sell
43,200
-26,836
-38% -$1.32M ﹤0.01% 1644
2017
Q3 		$3.73M Hold
70,036
– – ﹤0.01% 1344
2017
Q2 		$4.35M Buy
70,036
+4,987
+8% +$300K 0.01% 1332
2017
Q1 		$4.41M Buy
65,049
+3,501
+6% +$267K 0.01% 1306
2016
Q4 		$4.33M Hold
61,548
– – 0.01% 1308
2016
Q3 		$4.37M Hold
61,548
– – 0.01% 1277
2016
Q2 		$3.01M Sell
61,548
-5,353
-8% -$346K ﹤0.01% 1442
2016
Q1 		$4.24M Buy
66,901
+10,024
+18% +$656K 0.01% 1276
2015
Q4 		$6.38M Buy
56,877
+7,240
+15% +$724K 0.01% 1121
2015
Q3 		$4.78M Buy
49,637
+24,027
+94% +$2.75M 0.01% 1233
2015
Q2 		$2.62M Buy
+25,610
New +$1.99M ﹤0.01% 1722
2014
Q4 		– Sell
-3,765
Closed -$213K – 2054
2014
Q3 		$213K Buy
+3,765
New +$189K ﹤0.01% 2030

Other funds holding RARE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

New York State Common Retirement Fund's RARE Position: Q2 2026 in Review

New York State Common Retirement Fund held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 33,700 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

New York State Common Retirement Fund first reported a position in RARE in Q3 2014 and has held it in 46 quarters since. The position peaked at $20.5M in Q4 2020. 70 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • New York State Common Retirement Fund held 33,700 shares of Ultragenyx Pharmaceutical worth $1.13M as of Q2 2026.
  • New York State Common Retirement Fund left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1700 holding.
  • New York State Common Retirement Fund first reported a position in Ultragenyx Pharmaceutical in Q3 2014 and has held it in 46 quarters since.
  • New York State Common Retirement Fund's Ultragenyx Pharmaceutical position peaked at $20.5M in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.